Pizotifen is a class of benzocycloheptene, which is commonly sold under name Sandomigran. Pizotifen is primarily used in prevention and to reduce frequency of migraine and cluster headaches. It is effective and its use is limited by side effects such as drowsiness and weight gain. It is seen to be effective in treatment of severe cases of erythromelalgia, a rare neurological disease. Patients with kidney dysfunction, history of epilepsy, and symptoms such as depression are not advised to take pizotifen drug.
COVID-19 Impact Analysis
COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the pizotifen market.
Top Impacting Factors
- Increase in cases of migraine, surge in neurological disorders, rise in demand for anti-migraine drugs, increase in awareness of brain & neurological disorders, and surge in aging population are the key factors that drive the growth of pizotifen market.
- In addition, advantage and effectiveness related use of pizotifen such as quick relief from migraine, rise in private & government funding in healthcare sector, easy availability of skilled professionals, agreement & joint venture by key market players to improve quality of drugs, launch of novel developed drug in market, technological development such as new discoveries, and increased potency of drugs boost the market growth for pizotifen market.
- However, adverse effects related to the use of pizotifen medication such as weight gain, drowsiness, and other complications restrain the growth of pizotifen market.
- Contrarily, increase in awareness regarding treatment and prevention of migraine and government initiatives for regulatory approvals are expected to offer lucrative opportunities for the expansion of the market.
Market Trend
Rise in R&D Activities to Develop Novel Pizotifen Product
In 2021, an article was published on pizotifen. The article states that HTR2C inhibitor drug pizotifen acts as a suppressor of EMT-mediated metastasis.
In 2019, new report was discovered that Pizotifen represses the practicality of gastric malignancy MNK45 and AGS cells. A CCK8 test was done to decide the impact of pizotifen on the suitability of gastric disease cell lines MNK45 and AGS.
Surge in Migraine and Cluster Headache Treatment Procedures
Increase in cases of migraine & cluster headaches, increase in medical facility services in rural areas, and surge in demand for rapid pain relief drugs drive the growth of pizotifen market. As per the data of Migraine Research Foundation, roughly 39 million people in the U.S. are suffering from migraine and 1 billion people around the globe have migraine. This makes migraine as a third most common disorder in world. In addition, surge in health care expenditure, agreements, takeovers, joint ventures, & geographical expansions by key players in the market to increase R&D activities to improve quality of drugs, launch of novel drugs in market, and technological development are some factors that augment the market growth.
Key Benefits of the Report
- This study presents the analytical depiction of pizotifen market industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the market share.
- The current market is quantitatively analyzed to highlight the market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in coming years
Questions Answered in the Pizotifen Market Report
- Which are the leading players active in the pizotifen market?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities of the market?
- What future projections would help in taking further strategic steps?
- What is "pizotifen"?
- What is "pizotifen" market prediction in the future?
- Who are the leading global players in the "pizotifen" market?
- What are the current trends and predicted trends?
- What are the key benefits of the "pizotifen" market report?
Pizotifen Market Report Highlights
| Aspects | Details |
 By Product Type |
|
 By Application |
|
 By Distribution Channel |
|
 By Region |
|
 Key Market Players | Kalbe, Laema Chemi Pharma, AFT Pharmaceuticals, Aristopharma, Teva Pharmaceuticals, Beximco Pharmaceuticals Ltd., Novartis, Sine Pharmaceuticals, Duopharma Biotech |
Loading Table Of Content...
